News
Blazing new paths for biotech
1+ hour, 48+ min ago (154+ words) Drug Discovery and Development By Brian Finrow & Kevin Klowden | June 10, 2026 But the investing weather has changed: there is now greater caution both from U. S. regulators and investors, which has dovetailed with both a surplus of capital and increased regulatory streamlining in…...
Ginkgo, Tangible and Inductive Bio aim to move ADME decisions from lead optimization to hit ID
17+ hour, 58+ min ago (570+ words) Drug Discovery and Development By Brian Buntz | June 10, 2026 The new ADME-One platform packages Ginkgo's automated Tier 1 assays, Tangible's compound-management workflow and Inductive Bio's human pharmacokinetic projection into a single service aimed at hit identification. The aim is to give medicinal…...
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson's
1+ day, 20+ hour ago (207+ words) Drug Discovery and Development By Brian Buntz | June 8, 2026 "There's an app for that." The app side of Remepy's hybrid drug tracks daily movement against a goal and prompts patients to log symptoms like pain and stiffness. (Image: Remepy) A trends…...
Salesforce lands 140 life sciences clients, pitches 'headless' AI to pharma
1+ week, 1+ day ago (482+ words) Drug Discovery and Development By Brian Buntz | June 1, 2026 A patient support program overview over dedicated to improving treatment adherence. (Image: Salesforce) "The 140 represents customers across our entire portfolio," said Joe Ferraro, SVP and GM of life sciences at Salesforce, "regardless…...
Immunai's digital 'plumbing' keeps Astra Zeneca coming back
2+ week, 6+ day ago (295+ words) Drug Discovery and Development By Brian Buntz | May 21, 2026 That kind of cross-functional coordination points to the deeper challenge Immunai is trying to address: the infrastructure bottlenecks that slow drug development. Bringing a new drug to market costs $2. 67 billion on average…...
e Clinical Solutions study models 241% ROI from AI-powered clinical trial data platform
1+ mon, 3+ day ago (157+ words) Drug Discovery and Development By Brian Buntz | May 7, 2026 Imagine you were in charge or managing a project worth potentially billions of dollars that had upwards of six million data points. You could have any system you devise in the world…...
BD, Wellstar connect pharmacy-to-bedside medication management with AI
1+ mon, 4+ day ago (227+ words) Drug Discovery and Development By Brian Buntz | May 5, 2026 Wellstar Health System is partnering with BD to deploy a new AI-powered medication management tool across its hospitals. [Image courtesy of Wellstar] A clinician uses BD Pyxis Pro automated dispensing cabinets, part…...
How Immuto Scientific pairs AI and mass spec for a step change in protein structure throughput
1+ mon, 3+ week ago (327+ words) Drug Discovery and Development By Brian Buntz | April 15, 2026 "We can get data on about 1000 samples per week with our platform, so that roughly translates to something like 100 structures per week," Daniel Benjamin, Ph. D. , co-founder and CTO of Immuto Scientific, said…...
Amazon Bio Discovery cut MSK antibody design from a year to weeks, AWS says
1+ mon, 3+ week ago (228+ words) Drug Discovery and Development By Brian Buntz | April 14, 2026 Amazon Web Services today launched Amazon Bio Discovery, an application that routes AI-designed antibody candidates directly to DNA Synthesis firm Twist Bioscience and the techbio Ginkgo Bioworks for synthesis and testing, with…...
Beyond the binary: the convergence of small and large molecules
2+ mon, 2+ week ago (1310+ words) Drug Discovery and Development By Julia Rock-Torcivia | March 24, 2026 Pharmaceutical R&D is at an inflection point, a rapid convergence of technologies, data and biology that is reshaping how drugs are discovered and developed. The small molecule versus biologic binary is…...